NCT00266617View on ClinicalTrials.gov

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive Chemotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 1990

Conditions
AnemiaNeoplasms
Interventions
DRUG

epoetin alfa

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00266617 - A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive Chemotherapy | Biotech Hunter | Biotech Hunter